Evaluation of two treatment regimens of pralidoxime.
Ambadekar
N
N
D000931:Antidotes / Q000008:administration & dosage* / Q000627:therapeutic use*; D006801:Humans; D062025:Organophosphate Poisoning; D011041:Poisoning / Q000188:drug therapy*; D011220:Pralidoxime Compounds / Q000008:administration & dosage* / Q000627:therapeutic use*
D000931:Antidotes; D011220:Pralidoxime Compounds; C028797:pralidoxime